CyberNew CyberNew
Ransomware & Malware BleepingComputer 1 month ago

Veradigm warns of patient data breach after ransomware gang claims attack

CN
CyberNew Threat Research Desk
• Original Reporting: BleepingComputer
CyberNew Threat Intel Assessment
Assessed Severity: HIGH
Impacted Surface
Enterprise Data & Identity Stores
Intelligence Sector
Ransomware & Malware

Analyst Takeaway

"Healthcare technology company Veradigm disclosed a data breach after a cybersecurity incident at one of its third-party vendors exposed patients' personal data. The company says the incident did not cause operational disruptions but affected a small number of customers. Formerly known as Allscripts Healthcare Solutions, Veradigm is a Chicago-based healthcare technology company that supplies..."

Recommended Defense & Mitigation

  • Access Review: Audit administrative roles, enforce phishing-resistant MFA, and review privilege escalations.
  • Credential Rotation: Rotate high-privilege service credentials and tokens associated with impacted services.
Curated & Verified by CyberNew Threat Intelligence Desk Standard Defense Framework (NIST / MITRE ATT&CK)

Veradigm warns of patient data breach after ransomware gang claims attack

Healthcare technology company Veradigm disclosed a data breach after a cybersecurity incident at one of its third-party vendors exposed patients' personal data.

The company says the incident did not cause operational disruptions but affected a small number of customers.

Formerly known as Allscripts Healthcare Solutions, Veradigm is a Chicago-based healthcare technology company that supplies medical practices with electronic health records, e-prescribing, patient-engagement, practice-management, and revenue-cycle software.

Thousands of hospitals, clinics, and biopharmaceutical firms across the United States use its solutions.

Get the report

Source Verification & Original Intelligence

This threat report was reviewed by CyberNew analysts and cross-referenced with primary security disclosures from BleepingComputer.

Primary Advisory →